Glycerin
- Product NDC
- 83324-284
- 11-digit product format
- 833240284
- Labeler code
- 83324
- Product ID
- 83324-284_424d91bf-a81e-a627-e063-6294a90a3c3b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin
- Dosage form
- SUPPOSITORY
- Route
- RECTAL
- Labeler
- Chain Drug Marketing Association Inc.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2025-10-29
- Substance
- GLYCERIN
- Active strength
- 2.1 g/1
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Glycerin
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCERIN | 2.1 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| PDC6A3C0OX | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 583084 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 424d91f0-ecf9-6d9b-e063-6394a90a8006 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83324-284-25 | Glycerin | 25 in 1 JAR | SUPPOSITORY | 25 | 1 | |
| 83324-284-50 | Glycerin | 50 in 1 JAR | SUPPOSITORY | 50 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Topcare Stool Softener | DOCUSATE SODIUM | TopCo Associates, LLC | 6f4fddda-4129-4087-b0e4-ababc5558484 | 2021-02-19 | Warnings | M007 |
| Stool Softener | DOCUSATE SODIUM | Allegiant Health | 30c9ff75-cee4-4632-86fd-acfdf5ee85af | 2020-10-27 | Warnings | M007 |
| Stool Softener | MARC GLASSMAN | Marc Glassman, Inc. | 909cd222-d836-416f-aa7d-deb4a0c5a560 | 2020-09-08 | Warnings | M007 |
| Senna Lax | SENNOSIDES 8.6MG | Allegiant Health | 94a9c24a-07c3-4535-b810-b7abc9fc5ad5 | 2019-12-11 | Warnings | M007 |
| Laxative Enteric Coated | BISACODYL 5MG | Marc Glassman, Inc. | ec34fc1e-d122-4fa4-859e-e89e3e12edd5 | 2019-09-18 | Warnings | M007 |
| Womens Laxative | BISACODYL | Marc Glassman, Inc. | aeb3c49b-cbf5-4a47-b19c-e77fbb987a49 | 2019-09-17 | Warnings | M007 |
| Bisacodyl 5mg | BISACODYL 5MG | Allegiant Health | 46a377f5-822b-496f-a73b-66d8f902680a | 2019-03-26 | Warnings | M007 |
| Laxative Enteric Coated | BISACODYL 5MG | Allegiant Health | 51f1c6c0-770c-4426-820b-bc1f42e143fd | 2019-02-07 | Warnings | M007 |
| Senna-Lax | SENNOSIDES | Marc Glassman, Inc. | 7dd97c54-2ba1-4629-87b9-1ba0913fe531 | 2016-12-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 583084 | glycerin 2.1 GM Adult Rectal Suppository | PSN | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 1 |
| 583084 | glycerin 2100 MG Rectal Suppository | SCD | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 1 |
| 583084 | glycerin 2.1 GM Rectal Suppository | SY | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 1 |
| 583084 | glycerin 82.5 % Adult Rectal Suppository | SY | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 83324-284-25 | 83324028425 | 25 SUPPOSITORY in 1 JAR (83324-284-25) | 25 suppository | 2025-10-29 | No | No | Current |
| 83324-284-50 | 83324028450 | 50 SUPPOSITORY in 1 JAR (83324-284-50) | 50 suppository | 2025-10-29 | No | No | Current |